Marea Therapeutics

NEWS

NextGen

BioSpace’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends

From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.

January 7, 2025

·

4 min read

·

Heather McKenzie

IN THE PRESS

Press Releases

Marea Therapeutics Provides Update on Corporate Progress Including Positive Topline Results from Phase 2a Clinical Trial of MAR001 for Cardiovascular Disease and Disclosure of Second Lead Pipeline Program for the Treatment of Acromegaly

January 9, 2025

·

4 min read

Press Releases

Marea Therapeutics Expands Management Team and Board of Directors

December 20, 2024

·

3 min read

Biotech Bay

Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases

June 18, 2024

·

6 min read

JOBS